Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 14, 2013, Pages 5594-5599

  Senyuk, Vitalyi ^a   Zhang, Yunyuan ^a,b   Liu, Yang ^a   Ming, Ming ^a   Premanand, Kavitha ^a   Zhou, Lan ^b   Chen, Ping ^c   Chen, Jianjun ^c   Rowley, Janet D ^c   Nucifora, Giuseppina ^a   Qian, Zhijian ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; MICRORNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; DNA METHYLATION; DOWN REGULATION; ECOTROPIC VIRAL INTEGRATION SITE 1; EMBRYO DEVELOPMENT; EPIGENETICS; GENE REPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMOGENESIS; MOUSE; MYELOPOIESIS; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TUMOR GENE; UPREGULATION;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; COLONY-FORMING UNITS ASSAY; DNA METHYLATION; DNA PRIMERS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICRORNAS; MYELOPOIESIS; NIH 3T3 CELLS; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84875825753     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302645110     Document Type: Article

References (44)

1. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116(2):281-297.
2. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24(4):857-864.
3. Leucht C, et al. (2008) MicroRNA-9 directs late organizer activity of the midbrainhindbrain boundary. Nat Neurosci 11(6):641-648.
4. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S (2011) MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 31(9):3407-3422.
5. Zhao C, Sun G, Li S, Shi Y (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 16(4): 365-371.
6. Delaloy C, et al. (2010) MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell 6(4):323-335.
7. Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB (2011) MicroRNA-9: Functional evolution of a conserved small regulatory RNA. RNA Biol 8(4):557-564.
8. Kim N, et al. (2011) Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res 41(2):170-183.
9. Arora A, et al. (2010) Prediction of microRNAs affecting mRNA expression during retinal development. BMC Dev Biol 10:1.
10. Bazzoni F, et al. (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106(13):5282-5287.
11. Nie K, et al. (2008) MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: A potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 173(1):242-252.
12. Nass D, et al. (2009) miR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19(3):375-383.
13. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y (2011) MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129(11):2611-2620.
14. Myatt SS, et al. (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70(1):367-377.
15. Hu X, et al. (2010) A microRNA expression signature for cervical cancer prognosis. Cancer Res 70(4):1441-1448.
16. Bandres E, et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125(11):2737-2743.
17. Heller G, et al. (2012) Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin Cancer Res 18(6):1619-1629.
18. Guo LM, et al. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276(19):5537-5546.
19. Tan HX, et al. (2010) MicroRNA-9 reduces cell invasion and E-cadherin secretion in SKHep- 1 cell. Med Oncol 27(3):654-660.
20. Luo H, et al. (2009) Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28:82.
21. Rodriguez-Otero P, et al. (2011) Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br J Haematol 155(1):73-83.
22. Lujambio A, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105(36):13556-13561.
23. Hildebrandt MA, et al. (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29(42):5724-5728.
24. Ma L, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12(3):247-256.
25. Minor J, et al. (2012) Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol 48(1):73-78.
26. Mucenski ML, Taylor BA, Copeland NG, Jenkins NA (1988) Chromosomal location of Evi-1, a common site of ecotropic viral integration in AKXD murine myeloid tumors. Oncogene Res 2(3):219-233.
27. Testoni N, et al. (1999) 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica 84(8):690-694.
28. Brooks DJ, et al. (1996) Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Br J Cancer 74(10):1518-1525.
29. Liu Y, Chen L, Ko TC, Fields AP, Thompson EA (2006) Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene 25(25):3565-3575.
30. Choi YW, et al. (2007) Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Lung Cancer 55(1):43-51.
31. Haase D, et al. (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients. Blood 110(13):4385-4395.
32. Buonamici S, et al. (2004) EVI1 induces myelodysplastic syndrome in mice. J Clin Invest 114(5):713-719.
33. Tothova Z, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128(2):325-339.
34. Friedman AD (2007) Transcriptional control of granulocyte and monocyte development. Oncogene 26(47):6816-6828.
35. Sykes SM, et al. (2011) AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146(5):697-708.
36. Dickstein J, et al. (2010) Methylation and silencing of miRNA-124 by EVI1 and selfrenewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc Natl Acad Sci USA 107(21):9783-9788.
37. Senyuk V, Premanand K, Xu P, Qian Z, Nucifora G (2011) The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA. PLoS ONE 6(6):e20793.
38. Morishita K, Parganas E, Matsugi T, Ihle JN (1992) Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 12(1):183-189.
39. Sitailo S, Sood R, Barton K, Nucifora G (1999) Forced expression of the leukemiaassociated gene EVI1 in ES cells: A model for myeloid leukemia with 3q26 rearrangements. Leukemia 13(11):1639-1645.
40. Li Z, et al. (2012) Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood 119(10):2314-2324.
41. Bissels U, Bosio A, Wagner W (2012) MicroRNAs are shaping the hematopoietic landscape. Haematologica 97(2):160-167.
42. Kim J, et al. (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220-1224.
43. Qian Z, et al. (2009) Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo. Leukemia 23(9):1650-1657.
44. Qian Z, Chen L, Fernald AA, Williams BO, Le Beau MM (2008) A critical role for Apc in hematopoietic stem and progenitor cell survival. J Exp Med 205(9):2163-2175.